Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: IRIDEX Corporation

Market Cap 1.97Cr 1.71Cr 1.57Cr 1.47Cr 2.75Cr 188.34Cr 2.81Cr 19Cr 7.27Cr 91Cr 7.38Cr 7.22Cr 315.66Cr P/E Ratio 2026 *
-22.6x
P/E Ratio 2027 * 56.5x
Enterprise Value 1.97Cr 1.71Cr 1.57Cr 1.47Cr 2.75Cr 188.34Cr 2.81Cr 19Cr 7.27Cr 91Cr 7.38Cr 7.22Cr 315.66Cr EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.35x
Free-Float
68.77%
Yield 2026 *
-
Yield 2027 * -
1 day-0.44%
1 week-2.09%
Current month+7.24%
1 month+7.24%
3 months-15.97%
6 months+16.02%
Current year-1.23%
1 week 1.09
Extreme 1.09
1.18
1 month 0.98
Extreme 0.98
1.2
Current year 0.95
Extreme 0.9496
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.64
Manager TitleAgeSince
Chief Executive Officer 54 01/10/2024
Director of Finance/CFO 68 18/12/2018
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 24/06/2020
Director/Board Member 54 01/09/2018
Director/Board Member 66 17/03/2022
Date Insider Type Main position Quantity % Market Cap.
08/06Buy

Chief Financial Officer

2,400 0.0138%
05/06Buy

Chief Financial Officer

2,521 0.0145%
03/06Buy

Chief Financial Officer

2,400 0.0138%
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%-2.09%+21.06%-40.42% 1.97Cr
-1.31%-1.37%+14.52%-9.21% 18TCr
+0.43%-0.97%-20.60%+32.24% 15TCr
-1.39%-2.94%-11.51%-23.90% 13TCr
-0.94%-1.90%-51.79%-6.41% 7.19TCr
+0.31%-1.33%+14.34%+0.84% 4.95TCr
-1.99%-0.72%-26.09%-34.75% 4.52TCr
-1.77%-6.48%+8.09%+9.16% 3.72TCr
-0.74%-4.26%+4.15%+40.28% 3.57TCr
+0.88%+0.88%-12.30%-17.76% 2.9TCr
Average -0.55%+0.91%-6.01%-4.99% 7.23TCr
Weighted average by Cap. -0.67%+1.56%-8.29%-1.08%

Financials

2026 *2027 *
Net sales 5.3Cr 4.6Cr 4.24Cr 3.97Cr 7.42Cr 507.48Cr 7.58Cr 51Cr 20Cr 244.62Cr 20Cr 19Cr 850.55Cr 5.68Cr 4.93Cr 4.54Cr 4.25Cr 7.95Cr 543.54Cr 8.12Cr 54Cr 21Cr 262Cr 21Cr 21Cr 910.99Cr
Net income -8L -7L -6L -6L -11.13L -7.61Cr -11.37L -75.86L -29.37L -3.67Cr -29.84L -29.2L -13Cr 4L 3L 3L 3L 5L 3.46Cr 5L 34.45L 13.34L 1.67Cr 13.55L 13.26L 5.79Cr
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
11/26/11 1.126 $ -0.35% 22,371
10/26/10 1.130 $ +0.89% 15,611
09/26/09 1.120 $ +0.90% 87,644
08/26/08 1.110 $ +1.83% 35,560
05/26/05 1.090 $ -5.22% 1,37,411
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.130USD
Average target price
2.750USD
Spread / Average Target
+143.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!